NCT06297616 A Study of LY3841136 in Japanese Participants With Obesity or Overweight Status COMPLETED Phase PHASE1
NCT06297603 Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06297590 A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease Status RECRUITING Phase PHASE1
NCT06292013 A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06280716 A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06280703 A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) Status RECRUITING Phase PHASE1
NCT06260722 Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06258174 A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants Status COMPLETED Phase PHASE1
NCT06252675 Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma Status RECRUITING Phase PHASE2
NCT06243198 A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT06240351 A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06238479 A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06235983 A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06230523 A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight Status COMPLETED Phase PHASE2
NCT06229366 [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06220669 A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06215521 A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants Status COMPLETED Phase PHASE1
NCT06215430 A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants Status COMPLETED Phase PHASE1
NCT06194500 A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants Status COMPLETED Phase PHASE1
NCT06194214 A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants Status COMPLETED Phase PHASE1